Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Curcumin for the Treatment of Precancerous Anal Lesions in Patients with HIV

Trial Status: active

This phase I trial tests the safety, side effects, and best dose of curcumin in HIV patients with abnormal (precancerous) anal lesions living with HIV. The use of curcumin, the yellow pigment in the spice turmeric, may prevent anal cancer from forming in HIV patients with precancerous anal lesions.